Search results

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Latest information on the scheduled supply of our nuclear medicine production.

Research indicates that the portable x-ray fluorescence (XRF) is an appropriate analytical technique for determining seafood provenance at external sites.

ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and produce less waste. 

A team of researchers including the University of Rochester, CSIRO and ANSTO has found methane emissions from human fossil sources have been greatly underestimated.

$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Multi-faceted approach to dating Australian Indigenous rock art from Kimberley region

Applications are now being accepted for the Industry foundations Scholarship.

ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.

New facility will greatly enhance Australia’s capability in stress engineering for industry

Two ANSTO scientists were part of a research team led by the University of Wollongong, who are finalists for the 2019 NSW Environment, Energy and Science (DPIE) Eureka Prize for Environmental Research.